94 related articles for article (PubMed ID: 1390240)
21. CD9 expression indicates a poor outcome in acute lymphoblastic leukemia.
Liang P; Miao M; Liu Z; Wang H; Jiang W; Ma S; Li C; Hu R
Cancer Biomark; 2018; 21(4):781-786. PubMed ID: 29286918
[TBL] [Abstract][Full Text] [Related]
22. Myeloid antigen expression in adult acute lymphoblastic leukemia: clinicohematological correlations and prognostic relevance.
Ferrara F; De Rosa C; Fasanaro A; Mele G; Finizio O; Schiavone EM; Spada OA; Rametta V; Del Vecchio L
Hematol Pathol; 1990; 4(2):93-8. PubMed ID: 2373674
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
[TBL] [Abstract][Full Text] [Related]
24. Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance.
Cantù-Rajnoldi A; Putti C; Saitta M; Granchi D; Foà R; Schirò R; Castagni M; Valeggio C; Jankovic M; Miniero R
Br J Haematol; 1991 Sep; 79(1):40-3. PubMed ID: 1911387
[TBL] [Abstract][Full Text] [Related]
25. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse.
Biondi A; Yokota S; Hansen-Hagge TE; Rossi V; Giudici G; Maglia O; Basso G; Tell C; Masera G; Bartram CR
Leukemia; 1992 Apr; 6(4):282-8. PubMed ID: 1316978
[TBL] [Abstract][Full Text] [Related]
26. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
[No Abstract] [Full Text] [Related]
27. Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia.
Rodríguez-Pardo VM; Aristizabal JA; Jaimes D; Quijano SM; de los Reyes I; Herrera MV; Solano J; Vernot JP
Hematol Oncol Stem Cell Ther; 2013; 6(3-4):89-100. PubMed ID: 24161606
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
Hurwitz CA; Gore SD; Stone KD; Civin CI
Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
[TBL] [Abstract][Full Text] [Related]
29. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.
van den Berk LC; van der Veer A; Willemse ME; Theeuwes MJ; Luijendijk MW; Tong WH; van der Sluis IM; Pieters R; den Boer ML
Br J Haematol; 2014 Jul; 166(2):240-9. PubMed ID: 24697337
[TBL] [Abstract][Full Text] [Related]
30. Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures.
Oritani K; Wu X; Medina K; Hudson J; Miyake K; Gimble JM; Burstein SA; Kincade PW
Blood; 1996 Mar; 87(6):2252-61. PubMed ID: 8630385
[TBL] [Abstract][Full Text] [Related]
31. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
32. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
[TBL] [Abstract][Full Text] [Related]
33. CD9 antigen mRNA is induced by hypertonicity in two renal epithelial cell lines.
Sheikh-Hamad D; Ferraris JD; Dragolovich J; Preuss HG; Burg MB; García-Pérez A
Am J Physiol; 1996 Jan; 270(1 Pt 1):C253-8. PubMed ID: 8772451
[TBL] [Abstract][Full Text] [Related]
34. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
Wu S; Korte A; Gessner R; Henze G; Seeger K
Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
[TBL] [Abstract][Full Text] [Related]
35. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.
Yamazaki H; Xu CW; Naito M; Nishida H; Okamoto T; Ghani FI; Iwata S; Inukai T; Sugita K; Morimoto C
Biochem Biophys Res Commun; 2011 May; 409(1):14-21. PubMed ID: 21549094
[TBL] [Abstract][Full Text] [Related]
36. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias.
Lavabre-Bertrand T; Duperray C; Brunet C; Poncelet P; Exbrayat C; Bourquard P; Lavabre-Bertrand C; Brochier J; Navarro M; Janossy G
Leukemia; 1994 Mar; 8(3):402-8. PubMed ID: 8127145
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
38. Intracellular and surface distribution of CD9 in human eosinophils.
Fernvik E; Halldén G; Hed J; Lundahl J
APMIS; 1995 Oct; 103(10):699-706. PubMed ID: 8534428
[TBL] [Abstract][Full Text] [Related]
39. Immunological detection of residual leukaemic disease in the bone marrow of children with acute lymphoblastic leukaemia.
Kumar S; Carr TF; Hann IM; Jones PH; Evans DI
Br Med J; 1978 Mar; 1(6112):544-6. PubMed ID: 272943
[TBL] [Abstract][Full Text] [Related]
40. In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.
Kaspers GJ; Pieters R; Van Zantwijk CH; De Laat PA; De Waal FC; Van Wering ER; Veerman AJ
Br J Cancer; 1991 Sep; 64(3):469-74. PubMed ID: 1911186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
